Georgia-AACE 2018 Annual Meeting Atlanta, GA.

Atlanta, GA US
January 26, 2018 to January 27, 2018

Welcome, and thank you for attending the Georgia-AACE 2018 Annual Meeting.

The Georgia Chapter of AACE program committee has worked very hard to provide a relevant activity for the practicing clinical physician and other healthcare providers seeking education with an emphasis in endocrine disease.

This program has been planned to provide pertinent scientific and clinical information to help you achieve the best solutions in the diagnosis and therapeutic management of patients presenting with endocrine disease. Attendees will obtain updates in not only common and uncommon endocrine disorders, but also newer treatment modalities.

Providing exceptional patient care requires continuing high quality education. The American Association of Clinical Endocrinologists (AACE) was founded in 1991 by a visionary group of leaders to serve as the active voice for clinical endocrinologists. The impetus behind AACE's efforts has always been quality and cost-effective patient care for those with endocrine diseases and disorders. We hope that you will find this program of great value to you in your practice.

Target Audience

Endocrinologists, MD/DOs, advance practice clinicians, and other interested healthcare professionals who are interested in the treatment of endocrine disease states that reside or practice in the state of Georgia.

Learning Objectives

  1. Report the prevalence of transgender persons in the United States
  2. List available resources for the care of transgender people
  3. Describe potential adverse events from arising from transgender hormone therapy
  4. Understand link between T2DM and CVD
  5. Understand evolution of regulatory requirements for T2DM meds
  6. Understand results from completed CV outcomes trials
  7. Define gestational diabetes and differentiate this diagnosis from type 1 and type two diabetes and pregnancy
  8. Calculate insulin doses based on body weight and week gestation
  9. Prescribe a diet and exercise program to treat diabetes and pregnancy
  10. Discuss the current research and evidenced based recommendations for treatment of subclinical hypothyroidism in elderly individuals
  11. Review therapeutic options for hypothyroidism and controversies regarding their appropriate use
  12. Develop a practical approach to the management of hypothyroid patients who have persistent symptoms despite biochemically adequate thyroid hormone replacement
  13. Discuss some of the most important adrenal-related publications in the past 1 year
  14. Apply knowledge from the recent literature to case management
  15. Debate the merits of the recent advances in adrenal disease
  16. Illustrate common clinical questions with regard to adrenal disorders
  17. Discuss novel approaches to difficult adrenal management issues
  18. Evaluate the challenges in operating in an environment of limited information
  19. Review the benefits and risks of HT/non-HT
  20. Discuss “designer estrogens”
  21. Review use, indications of Flibanserin for FSIAD
  22. Understand the clinical risk factors for developing post-surgical hypoparathyroidism after thyroidectomy and parathyroidectomy
  23. Adjust the treatment with conventional agents to manage postsurgical and genetic forms of hypoparathyroidism
  24. Understand the efficacy and safety data on the use of recombinant parathyroid hormone (1-84) in the treatment of hypoparathyroidism
  25. Select an appropriate lipoprotein measure for treatment
  26. Understand the potential benefits of using lipoprotein reducing drugs
  27. Have knowledge of the rationale for the discovery or creation of the several drugs currently available for treating lipoprotein disorders
Additional information
Available for MOC Points?: 
No
Practice Area: 
Diabetes
Hypoglycemia
Obesity
General Endo
Course summary
Available credit: 
  • 11.75 AMA
  • 11.75 Attendance
Course opens: 
01/26/2018
Course expires: 
01/27/2019
Event starts: 
01/26/2018 - 1:00pm
Event ends: 
01/27/2018 - 3:40pm
Cost:
$0.00

Program Agenda

* Please click the program's title to view each presentation.

Friday, January 26, 2018

1:00 – 1:30 PMRegistration Open & Break
1:30 – 1:45 PMWelcome Remarks & Pre-Session Attendee Assessment
Objectives
  1. After participating in a pre-meeting assessment tool, attendees will be able to recognize areas of potential shortcoming and strive to improve knowledge and consequential healthcare practices.
1:45 – 2:30 PMTransgender Medicine: 
What an endocrinologist needs to know in 2018

Vin Tangpricha, MD, PhD, FACE 
Objectives
  1. Report the prevalence of transgender persons in the United States
  2. List available resources for the care of transgender people
  3. Describe potential adverse events from arising from transgender hormone therapy
2:30 – 3:15 PMAnti-Hyperglycemic Agents and Atherosclerotic CV Disease - A Cardiologist’s Perspective
Darren McGuire, MD, MHSc 
Objectives
  1. Understand link between T2DM and CVD
  2. Understand evolution of regulatory requirements for T2DM meds
  3. Understand results from completed CV outcomes trials
3:15 – 3:45 PMBreak
3:45 – 4:30 PMDiabetes and Pregnancy
Lois Jovanovic, MD, MACE 
Objectives
  1. Define gestational diabetes and differentiate this diagnosis from type 1 and type two diabetes and pregnancy
  2. Calculate insulin doses based on body weight and week gestation
  3. Prescribe a diet and exercise program to treat diabetes and pregnancy
4:30 – 4:45 PMPost-Session Attendee Assessment 
Objectives
  1. At the conclusion of the meeting, attendees will be able to measure learning that occurred that will enable the use of new healthcare techniques and practices and to review or confirm existing care modalities.
4:45 – 5:30 PMReception

Saturday, January 27, 2018

7:00 – 7:45 PMRegistration / Continental Breakfast
7:45 – 8:15 AMWelcome Remarks & Pre-Session Attendee Assessment
Objectives
  1. After participating in a pre-meeting assessment tool, attendees will be able to recognize areas of potential shortcoming and strive to improve knowledge and consequential healthcare practices.
8:15 – 9:00 AMThyroid Hot Topics
Michael McDermott, MD
Objectives
  1. Discuss the current research and evidenced based recommendations for treatment of subclinical hypothyroidism in elderly individuals
  2. Review therapeutic options for hypothyroidism and controversies regarding their appropriate use
  3. Develop a practical approach to the management of hypothyroid patients who have persistent symptoms despite biochemically adequate thyroid hormone replacement
9:00 – 9:45 AMTony Karpas Memorial Lecture: Year in Adrenal
William Young, MD, FACP, FACE 
Objectives
  1. Discuss some of the most important adrenal-related publications in the past 1 year
  2. Apply knowledge from the recent literature to case management
  3. Debate the merits of the recent advances in adrenal disease
9:45 – 10:15 AMBreak
10:15 – 11:00 AME-mail Consults
William Young, MD, FACP, FACE 
Objectives
  1. Illustrate common clinical questions with regard to adrenal disorders
  2. Discuss novel approaches to difficult adrenal management issues
  3. Evaluate the challenges in operating in an environment of limited information
11:00 – 11:30 AMGA-AACE Business Meeting
11:40 – 12:40 PMLunch
12:50 – 1:35 PMMenopause and Newer Women's Health Therapies
Holly Thacker, MD 
Objectives
  1. Review the benefits and risks of HT/non-HT
  2. Discuss “designer estrogens”
  3. Review use, indications of Flibanserin for FSIAD
1:35 – 2:20 PMUpdate in the Treatment of Hypoparathyroidism
Dolores Shoback, MD 
Objectives
  1. Understand the clinical risk factors for developing post-surgical hypoparathyroidism after thyroidectomy and parathyroidectomy
  2. Adjust the treatment with conventional agents to manage postsurgical and genetic forms of hypoparathyroidism
  3. Understand the efficacy and safety data on the use of recombinant parathyroid hormone (1-84) in the treatment of hypoparathyroidism
2:20 – 3:05 PMLipoproteins, Genes, and Drugs
W. Virgil Brown, MD 
Objectives
  1. Select an appropriate lipoprotein measure for treatment
  2. Understand the potential benefits of using lipoprotein reducing drugs
  3. Have knowledge of the rationale for the discovery or creation of the several drugs currently available for treating lipoprotein disorders
3:05 – 3:30 PMPost Session Attendee Assessment 
Objectives
  1. At the conclusion of the meeting, attendees will be able to measure learning that occurred that will enable the use of new healthcare techniques and practices and to review or confirm existing care modalities.
3:30 – 3:40 PMClosing Remarks & Adjourn
Doubletree by Hilton Buckhead Atlanta
3342 Peachtree Rd NE
Atlanta, GA 30326
United States
+1 (404) 231-1234
 

W. Virgil Brown, MD
Charles Howard Candler Professor Emeritus
Emory University School of Medicine
Atlanta, GA

Lois Jovanovic, MD, MACE
Clinical Professor of Medicine
University of Southern California
Keck University Medical School
Los Angeles, CA

Michael McDermott, MD
Professor of Medicine and Clinical Pharmacy
University of Colorado Denver School of Medicine
Director, Endocrinology and Diabetes Practice
University of Colorado Hospital
Denver, CO

Darren K. McGuire, MD, MHSc
Professor of Medicine
University of Texas Southwestern Medical Center
Dallas, TX

Dolores Shoback, MD
Professor of Medicine
University of California
San Francisco, CA

Vin Tangpricha, MD, PhD, FACE
Professor of Medicine
Division of Endocrinology, Metabolism & Lipids
Emory University School of Medicine
Atlanta, GA

Holly L. Thacker, MD, FACP, CCD, NCMP
Professor and Director, Center for Specialized Women's Health
Cleveland Clinic
Executive Director, Speaking of Women's Health
Cleveland, OH

William F. Young, Jr., MD, MSc
Professor of Medicine, Mayo Medical School
Chair, Division of Endocrinology
Mayo Clinic
Rochester, MN

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the American Association of Clinical Endocrinologists (AACE) and the Georgia Chapter of AACE. The American Association of Clinical Endocrinologists (AACE) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The American Association of Clinical Endocrinologists (AACE) designates this live activity for a maximum of 8.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Available Credit

  • 11.75 AMA
  • 11.75 Attendance

Accreditation Period

Course opens: 
01/26/2018
Course expires: 
01/27/2019

Price

Cost:
$0.00
Please login or register to take this course.